0001104659-23-004095.txt : 20230117 0001104659-23-004095.hdr.sgml : 20230117 20230117090021 ACCESSION NUMBER: 0001104659-23-004095 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 23530431 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 DEFA14A 1 tm233526d1_defa14a.htm DEFA14A

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(
Amendment No. )

 

Filed by the Registrant. x
Filed by a Party other than the Registrant ¨

 

Check the appropriate box:

 

¨ Preliminary Proxy Statement
¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive Proxy Statement
x Definitive Additional Materials
¨ Soliciting Material under §240.14a-12

 

AVENUE THERAPEUTICS, INC.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

x No fee required

 

¨ Fee paid previously with preliminary materials.

 

¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

 

 

 

 

 

 

The following is a letter sent to certain shareholders of Avenue Therapeutics, Inc. in a mailing commenced on January 17, 2023

 

 

 

Dear Avenue Therapeutics’ Shareholder:

 

YOUR PARTICIPATION IS IMPORTANT – PLEASE VOTE TODAY!

 

According to our latest records, your proxy vote relating to the Avenue Therapeutics’ Annual Meeting of Stockholders has not yet been received.

 

You have until January 29, 2023 at 11:59 p.m. EST to vote your shares.
PLEASE VOTE TODAY following the instructions on your proxy card.

 

Item 1 ELECTION OF DIRECTORS Vote FOR
Item 2 RATIFY BDO USA, LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANT Vote FOR
Item 3 APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK Vote FOR
Item 4 APPROVE AN AMENDMENT TO OUR 2015 EQUITY INCENTIVE PLAN Vote FOR

 

If you have any questions please contact our proxy solicitor, Alliance Advisors, toll free at: 1-855-506-1762

 

If you have recently mailed your proxy card or cast your vote by phone or internet, please accept our thanks and disregard this request.

 

Sincerely,

 

Alexandra MacLean, M.D.

Chief Executive Officer

 

 

GRAPHIC 2 tm233526d1_defa14aimg01.jpg GRAPHIC begin 644 tm233526d1_defa14aimg01.jpg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end